MedTrace Logo

Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile in Prediabetic and Healthy Subjects

NCT05887791 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-12-17

No results posted yet for this study

Summary

To investigate the effect of two different dosages collagen hydrolysate (CH) on postprandial blood glucose and insulin profile in prediabetic and normo-glycaemic subjects.This will be investigated in a cross-over randomized double-blind placebo controlled study design.

Conditions

  • Healthy
  • Prediabetic State

Interventions

DIETARY_SUPPLEMENT

Collagen hydrolysate

Single dose

OTHER

Placebo

Single dose

Sponsors & Collaborators

  • BioTeSys GmbH

    collaborator OTHER

  • Rousselot BVBA

    lead INDUSTRY

Principal Investigators

  • Nicoletta Virgilio, PhD · Rousselot BV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2023-12-23
Completion
2024-04-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05887791 on ClinicalTrials.gov